Abstract: Compounds of the formula:
where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the picornaviral 3C protease. Also disclosed are compounds of the formula:
where the formula variables are as defined herein that advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as rhinovirus 3C proteases. Intermediates and synthetic methods for preparing such compounds are also described.
Type:
Grant
Filed:
December 1, 2000
Date of Patent:
February 4, 2003
Assignee:
Agouron Pharmaceuticals, Inc.
Inventors:
Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore O. Johnnson, Jr.
Abstract: Trovafloxacin acid salts are prepared via the hydrolysis of imine intermediates using mineral acid including, but not limited to, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, nitric acid, sulfuric acid, phosphoric acid, hydrochloric acid, hydrobromic acid, tartaric acid, citric acid, acetic acid, and maleic acid. Trovafloxacin acid salts are useful as antibiotic agents.
Type:
Grant
Filed:
August 26, 1999
Date of Patent:
March 19, 2002
Assignee:
Pfizer Inc.
Inventors:
Timothy Norris, Keith M. DeVries, Peter R. Rose